Back
SAB Biotherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
SABS
SAB Biotherapeutics
Last Price:
$2.20
Seasonality Move:
-16.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SABS is experiencing slight buying pressure.
SAB Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.17 | Buy |
| 20-day SMA: | 2.3 | Sell |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 2.38 | Sell |
| 8-day EMA: | 2.12 | Buy |
| 20-day EMA: | 1.65 | Buy |
| 50-day EMA: | 0.94 | Buy |
| 200-day EMA: | 0.29 | Buy |
SAB Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 49.35 | Sell |
| Chaikin Money Flow: | 18978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.62) | Sell |
| Bollinger Bands (100): | (1.46 - 2.28) | Buy |
SAB Biotherapeutics Technical Analysis
| Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SAB Biotherapeutics Stock
Is SAB Biotherapeutics Stock a Buy?
-
SAB Biotherapeutics share price is 2.22 while SABS 8-day simple moving average is 2.17, which is a Buy signal.
-
The stock price of SABS is 2.22 while SAB Biotherapeutics 20-day SMA is 2.30, which makes it a Sell.
-
SAB Biotherapeutics 50-day simple moving average is 2.15 while SABS share price is 2.22, making it a Buy technically.
-
SABS stock price is 2.22 and SAB Biotherapeutics 200-day simple moving average is 2.38, creating a Sell signal.
SABS Technical Analysis vs Fundamental Analysis
Sell
38
SAB Biotherapeutics (SABS)
is a Sell
Is SAB Biotherapeutics a Buy or a Sell?
-
SAB Biotherapeutics stock is rated a SellThe current SAB Biotherapeutics [SABS] share price is $2.22. The Score for SABS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
SAB Biotherapeutics Stock Info
Market Cap:
23.1M
Price in USD:
2.22
Share Volume:
75.9K
SAB Biotherapeutics 52-Week Range
52-Week High:
6.60
52-Week Low:
1.00
Sell
38
SAB Biotherapeutics (SABS)
is a Sell
SAB Biotherapeutics Share Price Forecast
-
What is the SAB Biotherapeutics stock price today?The SAB Biotherapeutics stock price is 2.22 USD today.
-
Will SABS stock go up or go down?SAB Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SAB Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SAB Biotherapeutics is overvalued.
Is SAB Biotherapeutics Stock a Buy?
-
SAB Biotherapeutics share price is 2.22 while SABS 8-day exponential moving average is 2.12, which is a Buy signal.
-
The stock price of SABS is 2.22 while SAB Biotherapeutics 20-day EMA is 1.65, which makes it a Buy.
-
SAB Biotherapeutics 50-day exponential moving average is 0.94 while SABS share price is 2.22, making it a Buy technically.
-
SABS stock price is 2.22 and SAB Biotherapeutics 200-day simple moving average is 0.29, creating a Buy signal.
Fundamental Analysis of SAB Biotherapeutics
Is SAB Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and a decrease next year of $0.65 per share.
Technical Analysis of SAB Biotherapeutics
Should I short SAB Biotherapeutics stock?
-
SABS Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting SAB Biotherapeutics is a Buy
-
SAB Biotherapeutics Relative Strength Index (RSI) is 49.35, which suggest SAB Biotherapeutics is oversold
-
The Bollinger Bands (25) for SAB Biotherapeutics is (2.14 - 2.62), which suggest SAB Biotherapeutics is a Buy
-
The Bollinger Bands (100) for SAB Biotherapeutics is (1.46 - 2.28), which suggest SAB Biotherapeutics is a Buy
* SAB Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.